Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions
Clinical trial NCT04753489 · UNKNOWN
Trial details
- NCT number
- NCT04753489
- Sponsor
- Pharmtechnology LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-13
- Primary completion
- 2021-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.